Family · Pharmaceutical analytical standards
Trelagliptin
A DPP-4 inhibitor (gliptin) for type 2 diabetes that boosts incretin hormones to help control blood sugar: it was approved in Japan in March 2015 and later also in India. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?Chemically it is a fluorinated derivative of alogliptin, another gliptin: compared with similar gliptins, however, it has a much longer duration of action.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
